Biotech Stocks Race Towards Solutions for Cutaneous T-Cell Lymphoma (CTCL)

Go back to Biotech Stocks Race Towards Solutions for Cutaneous T-Cell Lymphoma (CTCL)
(NASDAQ: CTXR) Delayed: 0.77 +0.05 (6.94%)
Previous Close $0.72    52 Week High $2.50 
Open $0.74    52 Week Low $0.40 
Day High $0.77    P/E N/A 
Day Low $0.67    EPS $0.00 
Volume 698,117